Abstract
Introduction: Intraductal papillary mucinous neoplasm (IPMN) is a mucin producing neoplasm that arises in the main pancreatic duct and/or its branches. The objective of this study is to analyze retrospectively the clinical, radiologic and pathologic features as well as the surgical results of the patients with diagnosis of IPMN. Methods: Patients with diagnosis of IPMN who underwent surgery were identified from January 2006 to September 2015, using the prospective data base of the Pancreas service at HNGAI. Results: A total of 16 patients were found (12 females and 4 males). The mean age was 67.68 years. 3 were main duct type IPMN, 7 branch type and 6 mixed type. The pain was the most frequent symptom (87.5%), 25% had pancreatitis. For the diagnosis 100% had CT scan, 90% MRI. 11 patients underwent pancreaticoduodenectomy, 4 distal pancreatectomy (1 laparoscopic) and 1 exploratory laparotomy. 2 patients had type C pancreatic fistula. 2 patients underwent reoperation, 1 had prolonged ICU stay (because of an intrahospitalary pneumonia), and 1 died. 7 patients had low grade dysplasia, 2 moderate dysplasia, 1 high grade dysplasia, 5 invasive carcinoma and 1 patient had lesion with low grade dysplasia and one concomitant adenocarcinoma of the pancreas. Conclusions: This entity is present in our country being more common in women. The branch type IPMN is the most frequent type. The pancreatic fistula is the most important complication and the mortality rate is low. The IPMN's malignacy potential founded was high.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.